Explore the latest breakthroughs in treating bipolar on 25th September with leading experts.
In this early evening webinar, we will be bringing the latest research on Bipolar to the fore.
You’ll hear talks from leading experts in clinical, research and lived experience-led approaches working in the field, and have the opportunity to ask questions in the Q&A.
Date: Thursday 25th September
Time: 5.15-6.30pm
Location: Online, Zoom
Cost: Free
Talks range from promising research on Bipolar and why it is important, to reducing the delay in the diagnosis of Bipolar, and what’s next for medications and talking treatments.
We will then share the progress of ASCEnD, a groundbreaking study which is currently recruiting, looking at the clinical and cost-effectiveness of the combination of the antipsychotic Aripiprazole and antidepressant Sertraline, in comparison with Quetiapine, for the treatment of Bipolar Depression.
Speaking at the event is Professor Tania Gergel, Director of Research, Bipolar UK; Dr Stuart Watson, Clinical Senior Lecturer in Psychiatry at Newcastle University; and Professor Carolyn Chew-Graham, Professor of General Practice Research, Keele University.
The event will be chaired by McPin Senior Service User Researcher John Gibson.
Speaking ahead of the webinar, he said:
“As someone who lives with a diagnosis of bipolar, I am very aware of the devastating impact it can have on quality of life, both for the individuals affected and their informal carers. While current treatments may be successful in managing symptoms, this often comes at the cost of debilitating side-effects, including sedation and weight gain.
“I welcome research into improved treatment options such as the ASCEnD study, which has enormous potential to contribute valuable learning to our understanding of bipolar. If ASCEnD demonstrates that the combination of aripiprazole and sertraline is effective and safe enough to be prescribed by GPs, it may very well go some way to reducing the pressure on patients on secondary care waiting lists, as well as on primary care services.”
The webinar will be of particular interest to people with lived experience of Bipolar, and carers of those with lived experience, as well as anyone working in related areas; however, all are welcome to come and hear about current developments in the field.
